//Tumor Antigen by Immunoassay-CA19-9

Indications

Multiple tumor markers are available for monitoring the response of certain malignancies to therapy and assessing whether residual tumor exists post-surgical therapy.

Levels are useful in following the course of patients with established diagnosis of pancreatic and biliary ductal carcinoma. The test is not indicated for diagnosing these two diseases.

Limitations

signs or symptoms suggestive of malignancy


https://www.cms.gov/medicare-coverage-database/details/ncd-details.aspx?NCDId=142&ncdver=1&bc=AAAAgAAAAAAA&
